CSPC Ouyi Pharmaceutical Co., Ltd. clinical trials
A subsidiary of CSPC Pharmaceutical Group Limited
The registry lists 30 studies whose lead sponsor is CSPC Ouyi Pharmaceutical Co., Ltd.. 15 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2026.
Where
- China
- 21
Registry sponsor names on this page
- CSPC Ouyi Pharmaceutical Co., Ltd.30 studies
Something wrong with this grouping? Tell us on the CSPC Pharmaceutical Group Limited page.
Studies
Recruiting first, then most recently updated. Showing 30 of 30. All CSPC Pharmaceutical Group Limited studies →
- Phase 2 Study of SYH2066 Tablets Compared With Placebo in Chinese Adult Patients With Respiratory Syncytial Virus Infection.Not yet recruitingNCT07881991Phase 2
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- Efficacy and Safety of SYH2069 Injection in Obese Participants Without Diabetes.Not yet recruitingNCT07803991Phase 2
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or MetforminNot yet recruitingNCT07796477Phase 2
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.RecruitingNCT07519109Phase 1
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic AcidNot yet recruitingNCT07623915Phase 3
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata PatientsNot yet recruitingNCT06562894Phase 2
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive DisorderRecruitingNCT06958692Phase 3
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque PsoriasisNot yet recruitingNCT06943950Phase 3
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic CancerNot yet recruitingNCT06571461Phase 3
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo PatientsRecruitingNCT06511739Phase 2
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With PresbyopiaNot yet recruitingNCT06451666Phase 3
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Study to Evaluate Pregabalin in Painful Diabetic Peripheral NeuropathyNot yet recruitingNCT06383702Phase 3
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011Not yet recruitingNCT06354114Phase 2
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant TumorsNot yet recruitingNCT05728541Phase 1
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid TumorsNot yet recruitingNCT05609019Phase 1
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Study of SYH2069 Injection in Healthy ParticipantsActive, not recruitingNCT07736391Phase 1
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Study of SYH2082 Injection in Healthy ParticipantsActive, not recruitingNCT07736404Phase 1
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 DiabetesActive, not recruitingNCT07026968Phase 3
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Study to Evaluate the Safety, Efficacy, and PPK of ABCD in Patients With IMDCompletedNCT07239765Phase 3
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive AspergillusCompletedNCT05707832Phase 3
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- Study of Irinotecan Liposome Injection in Patients With Advanced Breast CanceCompletedNCT04728035Phase 1
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract CancerTerminatedNCT05009953Phase 2
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)CompletedNCT04727853Phase 2
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque PsoriasisCompletedNCT05858047Phase 2
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- Bioequivalence Study of Olaparib Tablets Under Fasting and Fed Conditions in Healthy SubjectsCompletedNCT06360445Phase 1
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)Status unknownNCT05753865Phase 3
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast CancerStatus unknownNCT05274893Phase 1
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy SubjectsStatus unknownNCT04880512Phase 1
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic AdenocarcinomaStatus unknownNCT05047991Phase 2
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.
- Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.Status unknownNCT04482257Phase 1
Sponsor listed in the registry: CSPC Ouyi Pharmaceutical Co., Ltd.